Pulmonology Medical News about Budesonide; asthma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Effects of Inhaled Budesonide on Lung Function in Smokers and Nonsmokers With Mild Persistent Asthma
Chest, 08/28/09

O’Byrne PM et al. – Smoking asthmatics, not treated with ICS, have a greater decline in lung function than nonsmoking asthmatics. The benefits of inhaled budesonide on preventing lung function decline are similar in smokers and nonsmokers with mild persistent asthma.

Next >>
Cisplatin plus vinorelbine as first-line treatment for advanced...

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma
Pediatric Research, 10/29/09 Relevance Score: 88%

Budesonide/formoterol effects on metalloproteolytic balance in TGF-beta-activated human lung fibroblasts
Respiratory Medicine, 10/13/09 Relevance Score: 88%

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice
Respiratory Medicine, 10/13/09 Relevance Score: 87%

Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials
Respiratory Medicine, 11/18/09 Relevance Score: 83%

Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma
Drugs & Therapy Perspectives, 10/16/09 Relevance Score: 83%